BioNTech SE ADR rises Thursday, outperforms market
The BioNTech SE ADR BNTX rallied 1.59% to $117.64 Thursday, on what proved to be an all-around favorable trading session for ...
Updated Pfizer-BioNTech’s COVID-19 vaccine approved by Health Canada
Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine ...
Fintel on MSN4d
Morgan Stanley Upgrades BioNTech SE - Depositary Receipt () (BNTX)
Fintel reports that on September 24, 2024, Morgan Stanley upgraded their outlook for BioNTech SE - Depositary Receipt () ...
BioNTech SE ADR rises Monday, outperforms market
The BioNTech SE ADR BNTX inched 0.69% higher to $113.05 Monday, on what proved to be an all-around positive trading session ...
Health Canada approves Pfizer-BioNTech’s updated COVID-19 vaccine
Health Canada recently asked provinces and territories to get rid of their older COVID-19 vaccines to ensure the most current ...
The Globe and Mail1m
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
Active companies in the biotech industry this week include Sunshine Biopharma Inc. (NASDAQ: SBFM), Novavax, Inc. (NASDAQ: NVAX), REGENXBIO Inc. (NASDAQ: RGNX), BIONTECH SE (NASDAQ: BNTX), Abbvie (NYSE ...
Pharmaceutical Technology5d
BioNTech gets grant for rna lipoplex particles for targeted delivery and storage
Discover BioNTech SE's innovative RNA lipoplex patent, detailing advanced methods for stable RNA delivery, GMP production, and effective intravenous administration.
BioNTech SE (BNTX) Receives a Hold from Morgan Stanley
In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on BioNTech SE (BNTX – Research Report), with a ...
Pfizer v Moderna COVID vaccine patents battle to go to appeal in UK
Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...
Yahoo Finance5d
Pfizer Canada and BioNTech Receive Health Canada Approval of Omicron KP.2 Variant Adapted COVID-19 Vaccine
2 strain of the SARS-CoV-2 Omicron JN.1 lineage. KIRKLAND, QC, Sept. 24, 2024 /CNW/ - Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced today that Health Canada has authorized ...
FierceBiotech4d
OncoC4 founders take own science under their wing in new biotech merger
OncoC4 is taking AcroImmune—and its in-house clinical manufacturing capabilities—under its wing in an all-stock merger. | ...